E. I. du Pont de Nemours and Company (DuPont) - 1996 10-K Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 1996. DuPont is the world's largest chemical company, operating globally through approximately 20 strategic business units and six principal industry segments: Chemicals, Fibers, Life Sciences, Polymers, Petroleum, and Diversified Businesses. The company employs approximately 97,000 people in about 70 nations, with roughly 50% of consolidated sales derived from outside the United States. A significant portion of its petroleum operations is conducted through its wholly owned subsidiary, Conoco Inc.
Key Financial Metrics and Operational Data
Note: Specific consolidated revenue, net income, and cash flow figures are incorporated by reference to the 1996 Annual Report to Stockholders (Exhibit 13) and are not explicitly stated in the provided text.
- Debt Repayment: Essentially completed repayment of $8.3 billion in debt incurred in 1995 to fund the redemption of shares owned by The Seagram Company Ltd.
- Share Repurchases: Repurchased 156 million warrants issued to Seagram for $504 million.
- Market Capitalization: Aggregate market value of voting stock held by nonaffiliates was approximately $63.2 billion as of March 7, 1997.
- Outstanding Shares: 565,696,946 shares of common stock outstanding (excluding Flexitrust shares) as of March 7, 1997.
- Capacity Utilization: Sales as a percent of capacity were 88% in 1996 (compared to 86% in 1995).
- Petroleum Production (1996):
- Total Petroleum Liquids Production: 445,000 barrels per day (419,000 consolidated; 26,000 equity affiliates).
- Total Natural Gas Deliveries: 1,309 million cubic feet per day (1,285 million consolidated; 24 million equity affiliates).
- Refining Capacity: Total worldwide crude oil and condensate distillation capacity was 708,000 barrels per day at year-end 1996.
Material Changes and Strategic Developments
Significant corporate actions in 1996 included:
- Divestitures: Divested essentially all medical products businesses and sold 30% of its photomasks business via an initial public offering.
- Joint Ventures: Entered a 50-50 joint venture for its elastomers business with The Dow Chemical Company.
- Refining Integration: Conoco's 25% interest in the Karlsruhe, Germany refinery agreed to integrate with an adjacent refinery, increasing its interest to 18.75% upon completion in 1997.
- Marketing Changes: Sold its marketing subsidiary in Ireland to Statoil.
- Stock Split: The Board approved a two-for-one common stock split, subject to shareholder approval in April 1997.
Outlook, Risks, and Contingencies
Legal Proceedings and Contingencies:
- Benlate Litigation: Over 700 lawsuits filed regarding alleged crop damage and personal injury from "Benlate" 50 DF fungicide. Approximately 60 cases remain pending. DuPont maintains the product did not cause the damage. A $3.98 million personal injury verdict in Florida is under appeal.
- Polybutylene Plumbing: Settled a national class action in 1995, agreeing to contribute up to 10% of repair costs, capped at $120 million. Several dozen opt-out cases remain pending.
- Environmental Penalties:
- Agreed to a $1 million penalty with the EPA regarding TSCA audit compliance (paid and closed).
- Settled various other EPA and state agency violations (e.g., Denver refinery, Antioch Works, Circleville plant) with penalties ranging from $10,000 to $274,075, often including supplemental environmental projects.
- Settled a Clean Water Act lawsuit with the DOJ regarding pipeline releases for a $112,500 penalty.
Risks:
- Foreign Operations: Petroleum exploration and production outside the U.S. face risks of government actions (tax changes, nationalization, export controls) and civil unrest.
- Competition: Highly competitive in both chemical and petroleum sectors, with competition based on price, quality, and supply reliability.
- Seasonality: Life Sciences segment sales are seasonal (highest in Q1/Q2); Petroleum segment mix varies by season (gasoline in summer, heating oil in winter).
Investor Verification Checklist
- Verify the exact consolidated revenue, net income, and operating cash flow figures in the 1996 Annual Report to Stockholders (Exhibit 13), as these are not detailed in the 10-K text provided.
- Review the status of the Benlate fungicide litigation and the potential financial impact of the remaining 60 lawsuits and the pending Florida appeal.
- Confirm the final terms and shareholder approval status of the proposed two-for-one stock split.
- Assess the impact of the divestitures (medical products, photomasks) on future segment reporting and revenue streams.
- Monitor the integration of the Karlsruhe refinery and the completion of the new Melaka, Malaysia refinery scheduled for 1997.